Theranos founder and CEO Elizabeth Holmes speaking in San Francisco last year.The Edison machines were touted as revolutionary and were the main basis for the $9 billion valuation attained by the Palo Alto, Calif., company in a funding round in 2014.The company has told the Centers for Medicare and Medicaid Services that it has issued tens of thousands of corrected blood-test reports to doctors and patients, voiding some results and revising others, according to the person familiar with the matter.In response to questions from The Wall Street Journal about the blood-test corrections, Theranos spokeswoman Brooke Buchanan said: Excellence in quality and patient safety is our top priority and we ve taken comprehensive corrective measures to address the issues CMS raised in their observations.As these matters are currently under review, we have no further comment at this time.CMS also has threatened to revoke the California lab s federal license and impose fines against Theranos.
Troubled startup Theranos has voided two years' worth of blood-test results from its flagship Edison machines, reports The Wall Street Journal.Those machines are Theranos' main claim to fame.CEO Elizabeth Holmes rose to prominence on the huge promise that, with Edison, Theranos can test for blood-borne diseases with only a pinprick of blood from a fingertip.But amid larger concerns over the accuracy and viability of the Edison technology, Theranos has told federal regulators that it's thrown out all results from 2014 and 2015.That includes tests that Theranos did with Edison, as well as the ones it performed with traditional lab equipment, according to The Journal's report.That means that anybody who got a Theranos blood test during that period may have gotten wrong results.The Journal report indicates that physicians in Phoenix have gotten corrected results from Theranos in recent weeks.In fact, one patient went to the emergency room in 2014 based on a Theranos blood-test result, says the report — a result that's now been amended.The move to throw the test results out is a sign that Theranos is trying to show government agencies that it can regulate its own shortcomings."We've taken comprehensive corrective measures to address the issues CMS raised in their observations.As these matters are currently under review, we have no further comment at this time," the company said, referring to the US Centers for Medicare and Medicaid Services.NOW WATCH: How NASA s groundbreaking work on human blood can predict your reaction to certain drugsLoading video...
Troubled bio-tech startup Theranos has told the Centers for Medicare and Medicaid Services CMS that it voided two years of results from the blood tests that it once staked its future on, reports the Wall Street Journal.According to the WSJ, Theranos also told the CMS—which is currently investigating the startup for compliance issues—that it has issued tens of thousands of corrected blood test reports to doctors and patients, with some results voided and others revised.TechCrunch has contacted Theranos and the CMS for comment.The WSJ spoke to several doctors near Phoenix, Arizona who said they had received corrected reports, including one physician who sent a patient to the emergency room based on erroneous results from Theranos.The CMS is just one of several federal agencies currently investigating Theranos for issues connected to its diagnostic tests and business operations.The CMS investigation revolves around compliance issues at Theranos main lab in Newark, California and may result in a two-year suspension from owning or running a lab for Elizabeth Holmes, the company s founder, and Sunny Balwani, its former president.
You have to wonder what other errors Theranos has that it s going to need to correct.The latest issue surrounding the troubled lab-technology company: It has voided the results of two years worth of blood tests that were done with Theranos Edison blood-testing devices.The Wall Street Journal reported that Theranos has re-issued thousands of test results that it has corrected.The company processed approximately 890,000 tests a year in its labs.You read that right: Two years of blood tests were basically stricken from the record.The company s valuation ended up being based on a technology that Theranos itself had given up on.All of that can t help Theranos case that the doors of its Palo Alto headquarters, and its testing labs, should be kept open.The Centers for Medicare and Medicaid services are still considering pulling Theranos license to operate labs in California, and have proposed kicking Theranos Chief Executive and founder Elizabeth Holmes out of the blood-testing industry for two years and fining the company, to boot, according to the Journal.Last week, Sunny Balwani stepped down from his president and chief operating officer posts at Theranos rather than face the possibility of a two-year ban from the blood-testing industry himself.Photo: Theranos CEO Elizabeth Holmes in 2014.
Theranos CEO and founder, Elizabeth HolmesAfter federal regulators threatened to revoke Theranos license to perform blood tests and ban its CEO and COO from the industry altogether, the company reportedly issued tens of thousands of corrections to blood tests it performed.Theranos has also voided all of the 2014 and 2015 results reported from its once-famed Edison blood testing machines, according to the Wall Street Journal.The Edison machines, which were said to be able to perform more than 200 medical tests with just a few drops of blood, were key to the young biotech company earning a whopping $9 billion valuation in 2014.Yet, in the wake of reports that the machines were inaccurate and unreliable and that employees were unqualified and failing to follow proper protocols and fix problems, the company acknowledged that it had completely stopped using the devices in June 2015.The unprecedented number of corrected lab results are just one of the steps Theranos is taking to try to appease the Centers for Medicare and Medicaid Services, which in March threatened to revoke the company s license and ban CEO and founder Elizabeth Holmes, and its president and COO, Sunny Balwani, from blood testing.Theranos has since hired new clinical laboratory advisors and it was announced last week that Balwani is leaving the company.
Photo: Jeff Chiu/APTroubled start-up Theranos has voided some two years' worth of blood-test results from its flagship Edison machines, reports The Wall Street Journal.But amid larger concerns over the accuracy and viability of the Edison technology, Theranos has told federal regulators that it's thrown out all results from 2014 and 2015.The move to throw the test results out is a sign that Theranos is trying to show government agencies that it can regulate its own shortcomings.That's important because Theranos is facing a criminal investigation and it's trying to prevent further problems."We've taken comprehensive corrective measures to address the issues CMS raised in their observations.As these matters are currently under review, we have no further comment at this time," the company said, referring to the US Centers for Medicare and Medicaid Services.
Witness the debacle that has dogged Theranos Inc. and its promise of being able to run multiple blood tests based on very small samples using its proprietary Edison device.Now, the WSJ is reporting that Theranos has 'voided' two years of Edison blood tests.It underscores the fact that Theranos has been unable to meet standards for accuracy advertised by Edison, a fact revealed during an FDA inspection of the company's facilities that showed substantial documentation of the product's failure.Needless to say, a blood testing device that cannot produce reliable results is potentially disastrous to individuals and medical practioners seeking to make treatment or lifestyle decisions based on the data provided by Theranos.The company's founder and CEO Elizabeth Holmes is facing a potential ban on providing blood testing services for as long as two years from federal regulators, as is recently-departed executive Sunny Balwani.Edison tests were available primarily through Walgreens pharmacy locations, which is a partnership that also looks to be in doubt as regulatory agencies circle Theranos in a bid to shut down its operations.
ASSOCIATED PRESSThe Theranos saga hit another low last week when the company informed regulators that it was voiding two years of tests from its Edison blood testing devices and sending of tens-of-thousands of revised tests results to doctors.Sadly, we have seen too much of this in the technology world — ethical lapses and lack of disclosure to shareholders.Look for leaders who engage in debate with people who understand the core technology and may fortify or enhance the original concept.Beware of leaders who hide behind the cloaks of marquee names.When they join a board, venture capitalists have a fiduciary duty to represent the interests of all shareholders, not only their funds.Their prominent governance apologists celebrated e-board governance, a self-righteous term replacing traditional diligent governance.
For the past four years, Tommy Edison has vlogged his experience as a blind man in a world full of people who can see.Some of these videos are revelatory, like when he explains how the blind use money, or what his dreams are like.Today he decided to find out what riding a rollercoaster feels like.He admits that the West Coaster at Santa Monica Pier isn t the craziest coaster in the park, but it s the one they ll let us film.He even gets a few jabs in at his cameraman s driving.The only time I ve seen him laugh more is when he read through the mean comments people have left on his videos.
Things keep getting worse for Theranos.A new lawsuit accuses Thernos of misleading customers about the accuracy of its blood tests, a week after the embattled Palo Alto company reportedly admitted to voiding two years of results.The class-action lawsuit filed in San Francisco federal court on Wednesday claims Theranos breakthrough product, which was supposed to provide a revolutionary way to conduct tests with just a few drops of blood taken from a patient s finger, didn t work.As a result, tens of thousands of patients may have been given incorrect blood-test results, been subject to unnecessary or potentially harmful treatments, and/or been denied the opportunity to seek treatment for a treatable condition, the complaint states.The Edison machines, used at Walgreens Pharmacies in California and Arizona to conduct the finger-prick tests, have caused Theranos significant headaches.The Wall Street Journal reported last week that the company told federal regulators it threw out all Edison test results for 2014 and 2015.The Centers for Medicare and Medicaid services are considering pulling Theranos licenses and banning founder Elizabeth Holmes from the industry.The lawsuit, brought on behalf of an Arizona man, claims Theranos told patients its tests were accurate and validated by the FDA and other bodies, when in reality the company was in hot water with regulators over its lack of compliance.In February 2015, an Edison device testing hormone levels failed 87 percent of quality-control checks, according to the complaint.The suit also claims Theranos misled the public by claiming it was using the Edison devices for certain tests, when it really wasn t.The suit seeks to represent thousands of people who purchased Edison blood tests.Photo: Elizabeth Holmes spoke about Theranos vision at the company s headquarters in Palo Alto in 2014.Karl Mondon/Bay Area News Group Tags: Theranos
It's an empty tree and has been since its creation on April 19th, 2016 by someone called Thomas Joseph Avila who has a google.com email address.Google's open source Android project already has code for Intel's Edison, Arduino-powered accessories and even TI's Panda single-board computers.Taking a slice of Pi is therefore not an outlandish move.There's no sign that work is in progress or of a timeline having been set for Android-on-Pi's completion.Android of course has a colossal collection of apps and is rather more familiar to many people than Raspbian and perhaps more approachable than even the NOOBS OS installer,The Register suspects Google and the Raspberry Pi foundation would not would not mind if Android on Pi gives more people a reason to acquire the machine.Or is Google instead trying to make Android a more viable target for the customised industrial Pis the Foundation is pitching as an Internet of Things thing?
Thanks to the Socket, you can now transform any old light bulb into a connected bulb — just screw Socket into a lighting fixture, insert a standard light bulb, and know that you ve turned a 20th century appliance into a 21st century smart home item.Once you download the free iDevices Connected app, you can dim your lights, adjust the customizable color ring light, and otherwise control your lightbulb from your smartphone.You can also create a schedule for your lights — whether that s a dimming cadence or a certain mood for a certain time — and let it run on its own even if you re not at home.First announced at CES 2016, the Socket joins the iDevice Thermostat and Switch, which also allow iOS device users to control various elements of their homes by way of their iPhone, iPad, or iPod Touch.Indeed, iDevice says, their entire line of products are meant to give users a simple way to customize their home and enhance everyday life.The Socket is compatible with standard Edison light bulbs up to 60 watts, and promises to fit into conventional lighting receptacles which means you won t have to redecorate your entire home to make it more tech-friendly .
Theranos CEO and founder Elizabeth Holmes.Apparently, Walgreens also feels hoodwinked.Currently, Theranos runs 45 wellness centers in Arizona and California, including 40 in Walgreens stores.Prior to signing the deal, Walgreens executives and consultants made several attempts to look over Theranos shoulder and check that its famed Edison blood testing devices worked as the company said.But the machine only spit out test results such as low and high so that Walgreens couldn t compare the results to standard blood testing equipment.Those broken promises and the risks they posed to patient health spurred two Theranos patients to file lawsuits against the company Wednesday and Thursday, respectively.
View photosMoreA man stands in the middle of Grand Central Terminal as he speaks on a cell phone, as passengers face limited train service on the New Haven Line between Stamford Station and Grand Central Terminal due to a Con Edison power problem in New York, September 25, 2013.REUTERS/Zoran MilichWASHINGTON Reuters - Police do not need a warrant to obtain a person's cellphone location data held by wireless carriers, a U.S. appeals court ruled on Tuesday, dealing a setback to privacy advocates.The ruling overturns a divided 2015 opinion from the court's three-judge panel and reduces the likelihood that the Supreme Court would consider the issue.Judge James Wynn disagreed, arguing that users do not discretely submit their location the way they would when dialing a phone number or depositing money into a bank.Last month, a panel of the 6th U.S.Circuit Court of Appeals also held that no warrant was required to obtain such data.
Theranos CEO Elizabeth Holmes is worth exactly $0, according to Forbes, the go-to publication for assessing the wealth of the world's billionaires.Last month Theranos, the troubled blood-testing startup, voided two years' worth of blood-test results from its flagship Edison machines.This is just the latest in a series of blows for the company, which began with a high-profile exposé from The Wall Street Journal last year that called the company's underlying technology into question.How did Forbes arrive at the $0 number?Here is the methodology:FORBES spoke to a dozen venture capitalists, analysts and industry experts and concluded that a more realistic value for Theranos is $800 million, rather than $9 billion.That gives the company credit for its intellectual property and the $724 million that it has raised, according to VC Experts, a venture capital research firm.It also represents a generous multiple of the company s sales, which FORBES learned about from a person familiar with Theranos finances.Based on this, Forbes concluded that Holmes' 50% stake in Theranos is worth nothing.This is because she owns common stock, and would get paid out after investors who own preferred shares, according to VC Experts.So even if Theranos were liquidated, she wouldn't likely see any of that $800 million.NOW WATCH: There s an incredible new workout on water where you run on floating matsLoading video...
Speaking at Recode's Code Conference, Google CEO Sundar Pichai said the company plans to 'put more thought' into its Nexus devices, which could include customising the Android software that runs them.Richard Windsor, analyst at Edison Investment Research, says that this move from Google could signal the tech giant's intention to ready take complete control of Android software."A proprietary version of Android will allow Google to fix the endemic fragmentation that plagues Android and to take back control of software updates.However, there are different phones with varied software and applications that work in several ways, making Android phones hard to use and sometimes leading to less capacity when compared to iPhones that have hardware and software designed only by Apple.They have the best new features of Android and inspire manufacturing partners to implement them in their own devices.However, the move will not be wihout its challeneges, with Windsor saying:"The real problem with this move will be getting it past the Android developer community but here Oracle is the ace up Google's sleeve.
Anyone who s seen the Drunk History about the War of Currents knows Nikola Tesla was the electric Jesus who helped bring alternating current AC to the world, much to the chagrin of direct current DC proponent Thomas Edison.Laptops, solar cells, LED bulbs, and electric vehicles all run on DC power.We have AC and DC running through the walls and through its wall plugs to add flexibility to the type of power that can be delivered to the loads inside the house, whether it s your laptop or the TV or potentially the refrigerator, Wayne Snyder, NextEnergy s IT program manager, told Digital Trends when we toured the home.The intent is to make the system safer to use, there s less work that a licensed electrician has to do, there s more flexibility, says Snyder.Jenny McGrath/Digital Trends Depending on what the vehicle battery management system is capable of supporting, we can charge faster or slower, AC or DC, so it adds flexibility to the future electric vehicle and hybrid electrical vehicle cars that we test and demonstrate out here, says Snyder.The DC charging gun uses a communication language for smart-grid applications, Smart Energy Profile 2.0.
The system analyzes information including elevator use, occupancy, electric demand, weather and indoor temperatures, and recommends ways in real time to decrease energy use and costs—an estimated average savings of 50 cents a square foot for landlords.It s really been a ground-up effort from the operations team and engineers… The operating system, which Prescriptive Data has named Nantum, is set to be unveiled this week at a conference in San Jose, Calif., focused on technological innovations in the commercial real-estate industry.The company is looking at setting annual fees of 7.5 to 8 cents a square foot.A lot of platforms were collecting data and weren t showing you how to deal with it, said Zach Aarons, co-founder of MetaProp NYC, a real-estate technology accelerator and seed investment firm.So then software companies popped up to help you analyze what s coming out of your buildings.Nantum, according to Mr. Gilbert, grew out of conversations that Rudin Management had years ago with energy company Consolidated Edison Inc., which was looking to improve the electric grid.
Nest Labs announced on Tuesday a new feature of its Nest Thermostat that enables homeowners to take better advantage of energy providers Time of Use rate plans.Dubbed Time of Savings, the new feature will automatically adjust the thermostat so that less electricity is consumed to heat or cool the home while energy prices are the highest.Some regulatory agencies, including the California Public Utilities Commission, are mandating that energy providers implement such plans in order to encourage conservation, thereby reducing strain on the electrical grid.The thermostat will display a green gear icon when Time of Savings is active, and this information will also be displayed in the energy history report that Nest provides to its customers.Nest says it s also working with Southern California Edison to bring Time of Savings to that utility s customers.Why this matters: The competition has already aped most of Nest s thermostat design innovations, so initiatives like Time of Savings and Nest s earlier Seasonal Savings and Rush Hour Rewards programs are the best means the company has of differentiating its products.
You shouldn t have a fear of heights or enclosed spaces, says senior engineer Seth Flash.Ten stories high and capable of producing 1.2 million pounds of steam an hour, they feature components so tall that engineers erect scaffolding to get up close.Inside, workers wearing wearing hard hats, boots, hearing and eye protection, and respirators, shuffle about like Andy Dufresne leaving Shawshank.The spherical armor also means inspectors can roll the drone along surfaces and even up walls, making it a not quite as cute, but more practical version of BB-8.Drones will do more inspection work like this soon, because the FAA has eased restrictions on commercial UAVs.After 15 years of inspecting every inch of the steam boilers by hand, he s eager to turn the job over to a flying robot.